# Spero Therapeutics, Inc.: Form 8-K/A, filed Oct 16, 2023

- Company: [Spero Therapeutics, Inc.](/companies/spro.md) (CIK 1701108)
- Form: 8-K/A
- Filed: 2023-10-16
- Accepted by EDGAR: Oct 16, 2023, 16:01 ET
- Period: 2023-10-05
- Accession: 0001193125-23-256865
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1701108/000119312523256865/d563868d8ka.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1701108/000119312523256865/

## Items reported

- Item 5.03: Amendment to articles or bylaws
- Item 5.07: Shareholder vote results
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1701108/000119312523256865/d563868d8ka.htm

Filed Oct 16, 2023.
Source: SEC EDGAR, the filing index for accession 0001193125-23-256865. Last ingested by Listed: Nov 11, 2026, 04:12 ET. No prices; not investment advice.